On April 7, 2005 , the FDA asked Pfizer, Inc. to remove Bextra from the market in the United States and Europe , citing that the risks outweighed the drug’s benefits. 

Bextra was used to treat adult rheumatoid arthritis and the pain associated with menstrual cramping. 

If you or a loved one have taken Bextra and suffered any of the following injuries, you may be entitled to compensation:

• heart attacks
• strokes
• serious cardiovascular injury
• Stevens-Johnson Syndrome (a skin hypersensitivity disorder)